bcr_patient_barcode	bcr_drug_barcode	days_to_drug_therapy_end	days_to_drug_therapy_start	days_to_drug_treatment_end	days_to_drug_treatment_start	dosage_units	drug_category	drug_dosage	drug_name	number_cycles	regimen_indication	route_of_administration	therapy_ongoing	total_dose	total_dose_units	regimen_number	prescribed_dose	prescribed_dose_units	therapy_type	days_to_form_completion	bcr_drug_uuid	therapy_type_notes
TCGA-AF-2687	TCGA-AF-2687-D7471	96	54	null	null	null	[Not Applicable]	null	Xeloda	[Not Available]	ADJUVANT	Oral	NO	93,000	mg	1	1500 mg twice a day along with concurrent radaition Monday through Friday	mg	Chemotherapy	708	3041c9c2-446a-4fd8-a6b7-b4ea72dda4fd	[Not Applicable]
TCGA-AF-2687	TCGA-AF-2687-D7473	259	132	null	null	null	[Not Applicable]	null	Oxaliplatin	9	ADJUVANT	Intravenous (IV)	NO	1211	mg	2	129-145	mg	Chemotherapy	708	66493de1-960a-4d78-abdb-ad820db8bfc4	[Not Applicable]
TCGA-AF-2687	TCGA-AF-2687-D7474	259	132	null	null	null	[Not Applicable]	null	Leucovorin	9	ADJUVANT	Intravenous (IV)	NO	5750	mg	2	600-700	mg	[Not Available]	708	b1351850-ce3f-4280-8c28-f967e6a594a3	[Not Applicable]
TCGA-AF-2687	TCGA-AF-2687-D7475	259	132	null	null	null	[Not Applicable]	null	5 FU	9	ADJUVANT	Intravenous (IV)	NO	5699	mg	2	605-684	mg	Chemotherapy	708	e024567d-988f-4c5f-b624-b18ee2d0bc40	[Not Applicable]
TCGA-AF-2687	TCGA-AF-2687-D7476	261	132	null	null	null	[Not Applicable]	null	5 FU	9	ADJUVANT	Intravenous (IV)	NO	34193	mg	2	3629-4104	mg	Chemotherapy	708	0d0a7050-6694-40d7-8087-f5ea54967092	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D2991	239	85	null	null	null	[Not Applicable]	null	Bevacizumab	10	PALLIATIVE	Intravenous (IV)	NO	2363.5	mg	1	229.5 - 259.1	mg	Targeted Molecular therapy	549	5ae8e910-5b3a-4fb0-8bd2-f37b9756c396	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D2996	267	85	null	null	null	[Not Applicable]	null	Leucovorin	12	PALLIATIVE	Intravenous (IV)	NO	7200	mg	1	600	mg	[Not Available]	549	772bc81b-8c06-48f0-a915-68df8ceba7eb	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D2997	267	85	null	null	null	[Not Applicable]	null	Oxaliplatin	11	PALLIATIVE	Intravenous (IV)	NO	707	mg	1	50-129	mg	Chemotherapy	549	8675aae4-8055-487a-b80a-4e53c4629f87	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D2998	267	85	null	null	null	[Not Applicable]	null	5FU	12	PALLIATIVE	Intravenous (IV)	NO	7032	mg	1	580-608	mg	Chemotherapy	549	0cd90c9e-bd4f-4cbf-ad1d-dd6d457912e7	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3001	269	85	null	null	null	[Not Applicable]	null	5FU	12	PALLIATIVE	Intravenous (IV)	NO	42192	mg	1	3480-3648	mg	Chemotherapy	549	6dd36a05-450e-45a0-b0c5-579a3b63651b	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3007	344	316	null	null	null	[Not Applicable]	null	Aflibercept/ Placebo Study	3	[Not Available]	Intravenous (IV)	NO	537	mg	1	175-180	mg	[Not Available]	549	bf52814b-2808-468b-9ae6-49608c492c80	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3024	344	316	null	null	null	[Not Applicable]	null	Irinotecan	3	[Not Available]	Intravenous (IV)	NO	772	mg	1	256-259	mg	[Not Available]	549	e843e98b-59be-4d00-b606-7eaf5e9d9ac7	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3028	344	316	null	null	null	[Not Applicable]	null	Leucovorin	3	[Not Available]	Intravenous (IV)	NO	1716	mg	1	568-576	mg	[Not Available]	549	4d891da7-ccc2-4b3e-b531-0bbd6385e6a6	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3029	344	316	null	null	null	[Not Applicable]	null	5FU	3	[Not Available]	Intravenous (IV)	NO	1716	mg	1	568-576	mg	[Not Available]	549	1dcab074-5ee4-4818-89bf-d7fdd9de8818	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3030	346	316	null	null	null	[Not Applicable]	null	5FU	3	[Not Available]	Intravenous (IV)	NO	10296	mg	1	3408-3456	mg	[Not Available]	549	22e444fa-7135-4389-bad0-7f7bcdc45420	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3307	[Not Available]	379	null	null	null	[Not Applicable]	null	FUDR (Floxuridine)	6	[Not Available]	Intravenous (IV)	YES	40350	mg	2	1135-1500	mg	Chemotherapy	556	5df65b50-c401-4ff5-af88-293a113e284a	[Not Applicable]
TCGA-AF-2689	TCGA-AF-2689-D3308	[Not Available]	379	null	null	null	[Not Applicable]	null	Camptosar	6	[Not Available]	Intravenous (IV)	YES	2420	mg	2	330-430	mg	Chemotherapy	556	8c673e37-976e-454d-841d-a0888f2d93ed	[Not Applicable]
TCGA-AF-2692	TCGA-AF-2692-D9921	384	344	null	null	null	[Not Applicable]	null	Xeloda	[Not Available]	RECURRENCE	Oral	NO	87000	mg	1	1500	mg	Chemotherapy	474	8d16b3a4-228c-430e-a26c-6747b843381d	[Not Applicable]
TCGA-AF-3400	TCGA-AF-3400-D2753	137	97	null	null	null	[Not Applicable]	null	5FU	6	ADJUVANT	Intravenous (IV)	NO	14005	mg	1	459-470 Daily for 5 days Mon- Fri	mg	Chemotherapy	393	3ec1df07-49b6-45d9-abb2-137d5d95525f	[Not Applicable]
TCGA-AF-3400	TCGA-AF-3400-D2800	358	185	null	null	null	[Not Applicable]	null	Leucovorin	11	ADJUVANT	Intravenous (IV)	NO	6850	mg	2	600-850	mg	[Not Available]	394	0e287f64-1843-4bfa-a0e8-19be31c3cb81	[Not Applicable]
TCGA-AF-3400	TCGA-AF-3400-D2833	358	185	null	null	null	[Not Applicable]	null	Oxaliplatin	11	ADJUVANT	Intravenous (IV)	NO	1551	mg	2	130-177	mg	Chemotherapy	394	f5420dc8-d394-4f7f-9848-008df8cbc84b	[Not Applicable]
TCGA-AF-3400	TCGA-AF-3400-D2847	358	185	null	null	null	[Not Applicable]	null	5FU	11	ADJUVANT	Intravenous (IV)	NO	7300	mg	2	612-832	mg	Chemotherapy	394	2a24fcad-f207-47b7-87cf-f710d38df559	[Not Applicable]
TCGA-AF-3400	TCGA-AF-3400-D2850	360	185	null	null	null	[Not Applicable]	null	5-FU	11	ADJUVANT	Intravenous (IV)	NO	44067	mg	2	3672-4992	mg	Chemotherapy	394	a2e12b5b-e00e-4614-aaa9-973b603d189c	[Not Applicable]
TCGA-AF-3911	TCGA-AF-3911-D13456	106	68	null	null	null	[Not Applicable]	null	5FU	6	ADJUVANT	Intravenous (IV)	NO	13271	mg	1	468-477 mg daily X 5 days Monday- Friday during Radiation therapy	mg	Chemotherapy	613	93f15563-e1f4-4df9-98fe-2c058fa1aef0	[Not Applicable]
TCGA-AF-3911	TCGA-AF-3911-D13478	284	144	null	null	null	[Not Applicable]	null	Oxaliplatin	11	ADJUVANT	Intravenous (IV)	NO	1868	mg	2	137-183	mg	Chemotherapy	593	9cf10576-9771-4a03-ab78-4c2dc302073e	[Not Applicable]
TCGA-AF-3911	TCGA-AF-3911-D13479	299	144	null	null	null	[Not Applicable]	null	5FU	12	ADJUVANT	Intravenous (IV)	NO	10296	mg	2	852-860	mg	Chemotherapy	593	378a1cdd-b199-4005-b5a8-590fe60c777c	[Not Applicable]
TCGA-AF-3911	TCGA-AF-3911-D13480	299	144	null	null	null	[Not Applicable]	null	Leucovorin	12	ADJUVANT	Intravenous (IV)	NO	6200	mg	2	50-850	mg	[Not Available]	593	763988bf-65bc-4af6-affa-2d62417e581e	[Not Applicable]
TCGA-AF-3911	TCGA-AF-3911-D13481	301	144	null	null	null	[Not Applicable]	null	5FU	12	ADJUVANT	Intravenous (IV)	NO	61776	mg	2	5112-5160	mg	Chemotherapy	593	ac0aeb25-48f3-4491-a888-09bc7cd2757f	[Not Applicable]
TCGA-AF-3913	TCGA-AF-3913-D15339	304	231	null	null	null	[Not Applicable]	null	Oxaliplatin	3	PALLIATIVE	Intravenous (IV)	NO	[Not Available]	[Not Available]	1	Unknown	[Not Available]	Chemotherapy	713	55dec849-87fa-4e9d-b34a-25d3f86fd865	[Not Applicable]
TCGA-AF-3913	TCGA-AF-3913-D15342	304	231	null	null	null	[Not Applicable]	null	Xeloda	3	PALLIATIVE	Oral	NO	[Not Available]	[Not Available]	1	Unknown	[Not Available]	Chemotherapy	713	37cd71bc-2e4e-467d-8695-ebb6dae9c2e0	[Not Applicable]
TCGA-AF-3914	TCGA-AF-3914-D10864	104	60	null	null	null	[Not Applicable]	null	5 FU	7	ADJUVANT	Intravenous (IV)	NO	12265	mg	1	200-410 daily	mg	Chemotherapy	455	359d8f95-b037-463b-bebb-679c31c0ef3e	[Not Applicable]
TCGA-AF-3914	TCGA-AF-3914-D10865	294	132	null	null	null	[Not Applicable]	null	oxaliplatin	12	ADJUVANT	Intravenous (IV)	NO	1643	mg	2	118-150	mg	Chemotherapy	455	742fb3eb-c8eb-4377-ad4b-8f106d302e97	[Not Applicable]
TCGA-AF-3914	TCGA-AF-3914-D10886	294	132	null	null	null	[Not Applicable]	null	Leucovorin	12	ADJUVANT	Intravenous (IV)	NO	3150	mg	2	50-750	mg	[Not Available]	455	caf0a7a9-d006-46fa-9810-3cb754a26c74	[Not Applicable]
TCGA-AF-3914	TCGA-AF-3914-D10887	294	132	null	null	null	[Not Applicable]	null	5 FU	12	ADJUVANT	Intravenous (IV)	NO	7918	mg	2	555-736	mg	Chemotherapy	455	70ef1e70-9652-476a-a268-1280652bb1a8	[Not Applicable]
TCGA-AF-3914	TCGA-AF-3914-D10888	296	132	null	null	null	[Not Applicable]	null	5 FU	12	ADJUVANT	Intravenous (IV)	NO	47,508	mg	2	3330-4416	mg	Chemotherapy	455	9f639bf0-67cc-4ca3-a738-c7f03a214b21	[Not Applicable]
TCGA-AF-4110	TCGA-AF-4110-D13658	261	65	null	null	null	[Not Applicable]	null	Oxaliplatin	9	ADJUVANT	Intravenous (IV)	NO	1665	mg	1	185	mg	Chemotherapy	465	8e82086a-6e5b-4fd9-b884-c08049426228	[Not Applicable]
TCGA-AF-4110	TCGA-AF-4110-D13664	261	65	null	null	null	[Not Applicable]	null	5FU	9	ADJUVANT	Intravenous (IV)	NO	7875	mg	1	875	mg	Chemotherapy	465	0916a9a1-c34b-4f5f-82d9-bd1d903c605e	[Not Applicable]
TCGA-AF-4110	TCGA-AF-4110-D13665	261	65	null	null	null	[Not Applicable]	null	Leucovorin	9	ADJUVANT	Intravenous (IV)	NO	5875	mg	1	500-875	mg	[Not Available]	465	ea9270b1-82ca-4900-a127-946f0ec99902	[Not Applicable]
TCGA-AF-4110	TCGA-AF-4110-D13666	263	65	null	null	null	[Not Applicable]	null	5FU	9	ADJUVANT	Intravenous (IV)	NO	46800	mg	1	5200	mg	Chemotherapy	465	cbc1140c-d519-4b62-90fa-5fe35623fa70	[Not Applicable]
TCGA-AF-6672	TCGA-AF-6672-D19804	182	43	null	null	null	[Not Applicable]	null	Oxaliplatin	11	ADJUVANT	Intravenous (IV)	NO	1578	mg	1	100-176	mg	Chemotherapy	null	3bf645a0-d4bb-4afe-85e0-bfbe69b64c7e	[Not Applicable]
TCGA-AF-6672	TCGA-AF-6672-D19805	196	43	null	null	null	[Not Applicable]	null	Leucovorin	12	ADJUVANT	Intravenous (IV)	NO	1400	mg	1	50-200	mg	[Not Available]	null	6ff436f2-b6b7-4a69-a1aa-cbc6fe45a89f	[Not Applicable]
TCGA-AF-6672	TCGA-AF-6672-D19806	196	43	null	null	null	[Not Applicable]	null	Fluorouracil	12	ADJUVANT	Intravenous (IV)	NO	8639	mg	1	615-828	mg	Chemotherapy	null	5d946f3e-2226-4819-bca2-6f6831cae629	[Not Applicable]
TCGA-AF-6672	TCGA-AF-6672-D19807	198	43	null	null	null	[Not Applicable]	null	Fluorouracil	12	ADJUVANT	Intravenous (IV)	NO	51786	mg	1	3690-4968	mg	Chemotherapy	null	dac0f8bc-2057-4165-bc75-9907572612fc	[Not Applicable]
TCGA-BM-6198	TCGA-BM-6198-D13221	272	89	null	null	null	[Not Applicable]	null	Xeloda	[Not Available]	ADJUVANT	Oral	NO	[Not Available]	[Not Available]	1	[Not Available]	[Not Available]	Chemotherapy	509	50c06958-f062-4dd4-8af3-2e20727551da	[Not Applicable]
TCGA-CL-4957	TCGA-CL-4957-D10094	61	30	null	null	null	[Not Applicable]	null	Oxaliplatin	3	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	unknown	65	mg/m2	Chemotherapy	942	c60e340b-0248-41fe-80fd-cef4fac101f3	[Not Applicable]
TCGA-CL-4957	TCGA-CL-4957-D10095	61	30	null	null	null	[Not Applicable]	null	Fluorouracil	3	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	unknown	1200	mg	Chemotherapy	946	001b65f0-aff7-4cb6-bf83-050f9370e6ae	[Not Applicable]
TCGA-CL-4957	TCGA-CL-4957-D10096	61	30	null	null	null	[Not Applicable]	null	Fluorouracil	3	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	unknown	400	mg/m2	Chemotherapy	942	d4aea7da-592a-47ce-ae43-a801599416d4	[Not Applicable]
TCGA-CL-4957	TCGA-CL-4957-D10097	61	30	null	null	null	[Not Applicable]	null	Leucovorin Calcium	3	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	unknown	400	mg/m2	Chemotherapy	942	287ad8e2-f73e-4ece-ab30-2fe789f2d532	[Not Applicable]
TCGA-DC-4745	TCGA-DC-4745-D16789	153	61	null	null	null	[Not Applicable]	null	Flourouracil	12	ADJUVANT	Intravenous (IV)	NO	9600	mg	1	800	mg	Chemotherapy	457	56e97bd0-ae1f-4321-9da2-1c4fcebd711d	[Not Applicable]
TCGA-DC-4745	TCGA-DC-4745-D16792	153	61	null	null	null	[Not Applicable]	null	Flourouracil	12	ADJUVANT	Intravenous (IV)	NO	29000	mg	1	2500	mg	Chemotherapy	457	3ba36058-d0eb-40b6-b5b6-1a57dc54e5ef	[Not Applicable]
TCGA-DC-4745	TCGA-DC-4745-D16795	153	61	null	null	null	[Not Applicable]	null	Leucovorin Calcium	12	[Not Available]	Intravenous (IV)	NO	9600	mg	1	800	mg	[Not Available]	457	2e038d05-efc6-45e4-b011-af9a6669eda3	[Not Applicable]
TCGA-DC-4745	TCGA-DC-4745-D16798	122	61	null	null	null	[Not Applicable]	null	Oxaliplatin	6	ADJUVANT	Intravenous (IV)	NO	1020	mg	1	170	mg	Chemotherapy	457	abf58812-4c12-4734-ba99-80b3e107572f	[Not Applicable]
TCGA-DC-4745	TCGA-DC-4745-D16799	153	122	null	null	null	[Not Applicable]	null	Pegfilgrastim	6	ADJUVANT	Subcutaneous (SC)	NO	36	mg	1	6	mg	[Not Available]	457	5935d581-743c-4b5e-892c-f90ab7754666	[Not Applicable]
TCGA-DC-6154	TCGA-DC-6154-D17883	242	91	null	null	null	[Not Applicable]	null	Flourouracil	12	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	1	unknown	[Not Available]	Chemotherapy	null	1535646c-5346-457e-8157-8083e674308f	[Not Applicable]
TCGA-DC-6154	TCGA-DC-6154-D17886	242	91	null	null	null	[Not Applicable]	null	Flourouracil	12	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	1	unknown	[Not Available]	Chemotherapy	null	ae7103e5-b431-4be0-b041-09485384352a	[Not Applicable]
TCGA-DC-6154	TCGA-DC-6154-D17888	242	91	null	null	null	[Not Applicable]	null	Leucovorin	12	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	1	unknown	[Not Available]	[Not Available]	null	31ab0762-6f93-45f0-910b-0cc012bfbde4	[Not Applicable]
TCGA-DC-6154	TCGA-DC-6154-D17889	242	91	null	null	null	[Not Applicable]	null	Oxaliplatin	12	ADJUVANT	Intravenous (IV)	NO	[Not Available]	[Not Available]	1	unknown	[Not Available]	Chemotherapy	null	ca705d57-a0eb-4310-8628-44af85e60bb9	[Not Applicable]
TCGA-DC-6681	TCGA-DC-6681-D17001	149	28	null	null	null	[Not Applicable]	null	Fluorouracil	8	ADJUVANT	Intravenous (IV)	NO	3920	mg	1	600	mg	Chemotherapy	null	0389e5fe-ae72-4684-8857-a1786571f0fc	[Not Applicable]
TCGA-DC-6681	TCGA-DC-6681-D17003	149	28	null	null	null	[Not Applicable]	null	fluorouracil	8	ADJUVANT	Intravenous (IV)	NO	15200	mg	1	1900	mg	Chemotherapy	null	70773b35-24f4-40be-8d08-4e29f9b40993	[Not Applicable]
TCGA-DC-6681	TCGA-DC-6681-D17004	149	28	null	null	null	[Not Applicable]	null	Leucovorin Calcium	8	ADJUVANT	Intravenous (IV)	NO	1280	mg	1	160	mg	[Not Available]	null	db7f6761-c134-48ba-b2f3-df57a979b4b1	[Not Applicable]
TCGA-DC-6681	TCGA-DC-6681-D17005	149	28	null	null	null	[Not Applicable]	null	Oxaliplatin	8	ADJUVANT	Intravenous (IV)	NO	850	mg	1	110	mg	Chemotherapy	null	f49b8f63-3f14-47e6-ac92-e3fe637e5299	[Not Applicable]
TCGA-DC-6683	TCGA-DC-6683-D16996	[Not Available]	60	null	null	null	[Not Applicable]	null	Fluorouracil	8	ADJUVANT	Intravenous (IV)	YES	6400	mg	1	800	mg	Chemotherapy	null	c35d6f62-4fe4-460c-9ca1-eef4461e775d	[Not Applicable]
TCGA-DC-6683	TCGA-DC-6683-D16997	[Not Available]	60	null	null	null	[Not Applicable]	null	Fluorouracil	8	ADJUVANT	Intravenous (IV)	YES	19200	mg	1	2400	mg	Chemotherapy	null	7b26e472-0f10-4ca1-9bb1-4dbd2a4852e9	[Not Applicable]
TCGA-DC-6683	TCGA-DC-6683-D16998	[Not Available]	60	null	null	null	[Not Applicable]	null	Oxaliplatin	8	ADJUVANT	Intravenous (IV)	YES	1360	mg	1	170	mg	Chemotherapy	null	102d8593-ffff-4a1e-8f0d-0d8e1dac97af	[Not Applicable]
TCGA-DC-6683	TCGA-DC-6683-D17000	[Not Available]	60	null	null	null	[Not Applicable]	null	Leucovorin Calcium	8	ADJUVANT	Intravenous (IV)	YES	6400	mg	1	800	mg	[Not Available]	null	d212da89-e3a1-4588-ab55-5f0513443f06	[Not Applicable]
TCGA-G5-6641	TCGA-G5-6641-D21865	212	100	null	null	null	[Not Applicable]	null	Oxaliplatin	9	ADJUVANT	Intravenous (IV)	NO	1862	mg	1	210	mg	Chemotherapy	null	d81354b9-0c34-4fcc-8b3f-e3f107f69534	[Not Applicable]
TCGA-G5-6641	TCGA-G5-6641-D21867	254	100	null	null	null	[Not Applicable]	null	Fluorouracil	12	ADJUVANT	Intravenous (IV)	NO	11632	mg	1	980	mg	Chemotherapy	null	5bf0d06d-1ace-46e0-a4ca-0994b79721e7	[Not Applicable]
TCGA-G5-6641	TCGA-G5-6641-D21868	254	100	null	null	null	[Not Applicable]	null	Leucovorin	12	ADJUVANT	Intravenous (IV)	NO	11632	mg	1	980	mg	Chemotherapy	null	9a002138-e55e-40ed-bc8d-9878e0bdcd74	[Not Applicable]
